(IVES) Dan IVES Wedbush AI - Overview
Etf: Software, Semiconductors, Cloud, Hardware
Dividends
| Dividend Yield | 0.41% |
| Yield on Cost 5y | 0.52% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.1% |
| Relative Tail Risk | 11.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | -4.60 |
| Character TTM | |
|---|---|
| Beta | 1.817 |
| Beta Downside | 1.902 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.56% |
| CAGR/Max DD | 1.92 |
Description: IVES Dan IVES Wedbush AI January 20, 2026
The Dan Ives Wedbush AI Revolution ETF (NYSE ARCA: IVES) tracks equity securities (or ADRs) of companies featured in the Dan Ives AI 30 Research Report, allocating at least 80 % of net assets-plus any investment-purpose borrowings-to those AI-focused firms. Because the fund is classified as non-diversified, it must meet the SEC’s 70 % concentration rule, which can amplify both upside and downside risk.
Key sector drivers that could influence IVES’s performance include the projected $1.5 trillion global AI market size by 2030, a historical 23 % compound annual growth rate for AI software revenues, and U.S. corporate AI spending exceeding $120 billion in 2023. Fresh KPIs to watch are the ETF’s expense ratio (currently 0.68 %), its assets under management (≈ $250 million as of Q4 2024), and the turnover rate, which has averaged 45 % over the past 12 months, reflecting active rebalancing in a fast-moving sector.
Given the fund’s heavy tilt toward a narrow set of high-growth tech names, investors should be mindful of valuation volatility and regulatory uncertainty around AI data usage. A disconfirming scenario-such as a broad slowdown in AI capital expenditures-would materially weaken the fund’s upside.
For a deeper, data-driven look at how IVES fits into the broader AI landscape, check out the analytics on ValueRay.
What is the price of IVES shares?
Over the past week, the price has changed by -5.96%, over one month by -5.73%, over three months by -9.76% and over the past year by +20.47%.
Is IVES a buy, sell or hold?
What are the forecasts/targets for the IVES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.3 | 6.1% |
IVES Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.02b USD (1.02b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.02b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.02b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 12.61% (E(1.02b)/V(1.02b) * Re(12.61%) + (debt-free company))
Discount Rate = 12.61% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)